Ledger.Open graph →
SEC Form D · Amendment · filed April 19, 2021

Phylos Bioscience, Inc

Offering
$26.0M
Sold
$12.2M
Exemption
Rule 506(c)
Industry
Other
Location
PORTLAND, OR
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (15)

Timothy J. Gregory · Portland, ORDirectorNishan Karassik · Portland, ORExec · DirectorRalph J. Risch · Portland, ORExec · DirectorDylan J. Anderson · Portland, ORExecDavid J. Patterson · Portland, ORDirectorDaniella Kranjac · Englewood Cliffs, NJDirectorDavid M. Mccoy · CHICAGO, ILExec · DirectorSilvio Marra, Md · Tinley Park, ILDirectorBeth Seidenberg · South San Francisco, CAExecMichael D. Feinglass · CHICAGO, ILExec · DirectorStanton T. Marcum · Sanibel, FLExec · DirectorAndrea T. Johnson · Florence, KYExec · DirectorMatthew Morgan · Boston, MADirectorRichard J. Foust · Austin, TXDirectorJohn Mazarakis · Miami Beach, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗